Pages that link to "Q28085375"
Jump to navigation
Jump to search
The following pages link to Synthetic Nanoparticles for Vaccines and Immunotherapy (Q28085375):
Displaying 50 items.
- Harnessing the immune system to improve cancer therapy (Q26738698) (← links)
- Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious Diseases (Q26744748) (← links)
- Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems (Q26748776) (← links)
- Self-assembling protein nanoparticles in the design of vaccines (Q26767097) (← links)
- Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy (Q26782566) (← links)
- Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens (Q27011190) (← links)
- Targeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future Perspectives (Q28066286) (← links)
- Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine (Q30400146) (← links)
- Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy (Q33875615) (← links)
- Preparation and immunogenicity of gold glyco-nanoparticles as antipneumococcal vaccine model (Q36202229) (← links)
- Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine. (Q36257481) (← links)
- Targeting Treg signaling for the treatment of autoimmune diseases (Q36372616) (← links)
- Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona Formation (Q36828184) (← links)
- Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response (Q37167802) (← links)
- Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy (Q37191649) (← links)
- Bio-inspired virus-like nanovesicle for effective vaccination. (Q37197146) (← links)
- Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities. (Q37577596) (← links)
- Specific and Efficient Uptake of Surfactant-Free Poly(Lactic Acid) Nanovaccine Vehicles by Mucosal Dendritic Cells in Adult Zebrafish after Bath Immersion. (Q37667212) (← links)
- Recruitment of bone marrow CD11b+Gr-1+ cells by polymeric nanoparticles for antigen cross-presentation (Q37710630) (← links)
- Harnessing Nanoparticles for Immunomodulation and Vaccines (Q37727724) (← links)
- Dendrimer-conjugated peptide vaccine enhances clearance of Chlamydia trachomatis genital infection (Q37834084) (← links)
- Cancer Nanomedicine: Lessons for Immuno-Oncology (Q38646361) (← links)
- Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines. (Q38680785) (← links)
- Targeting CpG Adjuvant to Lymph Node via Dextran Conjugate Enhances Antitumor Immunotherapy. (Q38699232) (← links)
- Mucosal vaccine delivery: Current state and a pediatric perspective (Q38727453) (← links)
- Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses (Q38737582) (← links)
- Biomaterials for enhancing anti-cancer immunity (Q38741829) (← links)
- Multifunctional nanoparticles for cancer immunotherapy (Q38744042) (← links)
- Development of poly(lactide-co-glycolide) nanoparticles functionalized with a mitochondria penetrating peptide. (Q38769737) (← links)
- Human immune cell targeting of protein nanoparticles--caveospheres. (Q38782237) (← links)
- Recent advances in the use of nanoparticles for allergen-specific immunotherapy. (Q38802840) (← links)
- Self-assembling peptide-based building blocks in medical applications (Q38830346) (← links)
- Emerging nanotechnologies for cancer immunotherapy (Q38837036) (← links)
- Strategies for designing synthetic immune agonists (Q38841677) (← links)
- Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines? (Q38886698) (← links)
- Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy? (Q38912004) (← links)
- The Density Code for the Development of a Vaccine? (Q38959835) (← links)
- Recent progress on the development of anisotropic gold nanoparticles: Design strategies and growth mechanism. (Q39091937) (← links)
- T cell immunoengineering with advanced biomaterials. (Q39157864) (← links)
- Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites. (Q39159035) (← links)
- Engineering self-assembled materials to study and direct immune function (Q39230209) (← links)
- Nanoformulations for combination or cascade anticancer therapy. (Q39380111) (← links)
- Glyco-gold nanoparticles: synthesis and applications (Q39419658) (← links)
- Calcium phosphate nanoparticles as a new generation vaccine adjuvant (Q39437472) (← links)
- Biologics to treat substance use disorders: Current status and new directions (Q39576940) (← links)
- Surface engineering for lymphocyte programming (Q40214162) (← links)
- Chitosan enhances nanoparticle delivery from the reproductive tract to target draining lymphoid organs (Q40230960) (← links)
- Synthetic nanovaccines for immunotherapy. (Q40280801) (← links)
- Self-Assembly Protein Nanogels for Safer Cancer Immunotherapy (Q41158336) (← links)
- Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody (Q41628716) (← links)